Carregant...

Towards personalized therapy in AML: In vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML

Guardat en:
Dades bibliogràfiques
Autors principals: Bernot, KM, Siebenaler, RF, Whitman, SP, Zorko, NA, Marcucci, GG, Santhanam, R, Ahmed, EH, Ngangana, M, McConnell, KK, Nemer, JS, Brook, DL, Kulp, SK, Chen, CS, Frankhouser, D, Yan, P, Bundschuh, R, Zhang, X, Dorrance, AM, Dickerson, K, Jarjoura, D, Blum, W, Marcucci, G, Caligiuri, MA
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3864138/
https://ncbi.nlm.nih.gov/pubmed/23660685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.147
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!